ferric citrate has been researched along with Secondary Hyperparathyroidism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, A; Kakimoto, K; Kemmochi, Y; Matsuo, A; Matsushita, M; Mimura, T; Miyamoto, K; Shinozaki, Y; Tanimoto, M; Uemura, A | 1 |
| Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F | 1 |
1 review(s) available for ferric citrate and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors | 2005 |
1 other study(ies) available for ferric citrate and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification.
Topics: Animals; Aorta; Calcium; Ferric Compounds; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Parathyroid Glands; Phosphates; Rats; Rats, Sprague-Dawley; Vascular Calcification | 2013 |